1. Market Research
  2. > Biotechnology
  3. > Biological Therapy Market Trends
  4. > Congestive Heart Failure - Pipeline Analysis

Congestive Heart Failure - Pipeline Analysis

  • May 2015
  • -
  • IQ4I Research & Consultancy Pvt. Ltd
  • -
  • 95 pages

“Congestive Heart Failure (CHF) Pipeline Analysis” gives comprehensive insight on the various drugs being developed for the treatment of CHF. The report covers all the drugs being developed in various development phases (Discovery to Phase 2 clinical). The pipeline focuses on disease modification and includes pharmacologic drugs, gene therapy, stem cell therapy and RNA-based therapeutics, but excludes symptom relief drugs like diuretics, acute treatments, angiotensins or thrombin inhibitors etc. The report also covers some of the hot targets in research for CHF treatments.


This report enables Pharmaceutical /Biotech companies, Academic institutes, Individual researchers, Investors, Medical technology companies, Service providers and other associated stake holders to identify and analyze the available licensing/collaborative opportunities in the CHF Drug market. The report also provide strategic insights on medicines that are likely to have an impact on CHF treatment space and potentially alter standards of care in CHF in the foreseeable future.
Current therapies focuses only to slow down the progression of the disease as more number of molecules are symptom relieving drugs, hence it provides a tremendous opportunity for upcoming therapies specific to CHF such as gene-based, stem cell-based and miRNA-based therapies, which reverses disease course and reduce the number of cardiac events.

Table Of Contents

Congestive Heart Failure - Pipeline Analysis
REPORT DESCRIPTION INTRODUCTION
• Causes and Symptoms
• Diagnosis
• Classification
• Compensatory mechanisms
• Unmet needs
EPIDEMIOLOGY
• Prevalence
• Incidence
• Hospitalizations
• Re-admissions
MARKET DATA
• Forecasting model
• Market dynamics
• Market sizing
• Cost burden
PIPELINE ANALYSIS
• Development stage
• Modalities
• Leading players
• Innovative approaches
• Associated targets
GENETHERAPY
• Pipeline
• Competitive landscape
STEMCELL THERAPY
• Pipeline
• Competitive landscape
RNA BASED THERAPEUTICS
• mi-RNA
• m-RNA
• Pipeline
• Competitive landscape
DRUGS (small molecules, recombinant proteins,
growth factors)
• Pipeline
• Competitive landscape
HOT TARGETS IN RESEARCH
MAJOR PLAYERS
• Company Profiles
• Overview, Pipeline and Deals
REFERENCES

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Regenerative Medicine Market: By Therapy (Cell Therapy, Gene Therapy, Others), By Product (Autologous Cell-Based, Allogeneic Cell-Based, Acellular), By Application (Orthopaedic & Musculoskeletal Spine, Dermatology, Others) & By Region-Forecast (2016-2021)

Regenerative Medicine Market: By Therapy (Cell Therapy, Gene Therapy, Others), By Product (Autologous Cell-Based, Allogeneic Cell-Based, Acellular), By Application (Orthopaedic & Musculoskeletal Spine, Dermatology, Others) & By Region-Forecast (2016-2021)

  • $ 5250
  • Industry report
  • September 2016
  • by Industry ARC

Regenerative medicines are capable of restoring the functionality of cells & tissues by treating a patient with laboratory grown cells and tissues. Regenerative medicines are used in a wide range of degenerative ...

Global Gene Therapy Partnering Terms and Agreements 2010 to 2016

Global Gene Therapy Partnering Terms and Agreements 2010 to 2016

  • $ 2995
  • Industry report
  • October 2016
  • by Currentpartnering

The Global Gene Therapy Partnering Agreements 2010-2016 report provides an understanding and access to the gene therapy partnering deals and agreements entered into by the worlds leading healthcare companies. ...

Viral Vectors and Plasmid DNA Manufacturing Market, 2016-2026

Viral Vectors and Plasmid DNA Manufacturing Market, 2016-2026

  • $ 2349
  • Industry report
  • October 2016
  • by Roots Analysis Private Ltd.

INTRODUCTION Gene therapy has emerged as a promising treatment option for various diseases (primarily the ones that currently have no cure) including cancers, inherited disorders and some viral infections. ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.